Geranylgeraniol prevents zoledronic acid-mediated reduction of viable mesenchymal stem cells via induction of Rho-dependent YAP activation

Long-term use of zoledronic acid (ZA) increases the risk of medication-related osteonecrosis of the jaw (MRONJ). This may be attributed to ZA-mediated reduction of viable mesenchymal stem cells (MSCs). ZA inhibits protein geranylgeranylation, thus suppressing cell viability and proliferation. Gerany...

Descripción completa

Detalles Bibliográficos
Autores principales: Singhatanadgit, Weerachai, Hankamolsiri, Weerawan, Janvikul, Wanida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society 2021
Materias:
Biochemistry, Cellular and Molecular Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187992/
https://www.ncbi.nlm.nih.gov/pubmed/34113452
http://dx.doi.org/10.1098/rsos.202066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187992/
https://www.ncbi.nlm.nih.gov/pubmed/34113452
http://dx.doi.org/10.1098/rsos.202066

Ejemplares similares